Literature DB >> 30756078

Posterior Reversible Encephalopathy Syndrome and Azathioprine.

Sara Vilas-Boas1, Ana Corte-Real1.   

Abstract

Posterior reversible encephalopathy syndrome (PRES) is a rare syndrome that presents with neurological manifestations, often associated with arterial hypertension. Magnetic resonance imaging (MRI) shows bilateral white matter oedema in the posterior vascular territories. Immunosuppression, (pre) eclampsia and autoimmune diseases can be implicated. A 27-year-old woman, with mixed connective tissue disease under azathioprine, was admitted in the emergency room in status epilepticus and with severe hypertension. The MRI showed bilateral oedema in a pattern compatible with PRES. There was clinical improvement after azathioprine suspension. PRES is typically reversible with prompt recognition of the syndrome and its trigger. The association with azathioprine is rare. LEARNING POINTS: Posterior reversible encephalopathy syndrome should be considered in patients with sudden onset of headache, altered consciousness and seizures.Recognition of this entity and identification of the trigger are essential for reversal of the clinical picture.Autoimmune diseases and some immunosuppressive drugs have been identified as causative, but reports of an association with azathioprine are very rare.

Entities:  

Keywords:  Posterior reversible encephalopathy syndrome; azathioprine; seizures

Year:  2019        PMID: 30756078      PMCID: PMC6372047          DOI: 10.12890/2019_001032

Source DB:  PubMed          Journal:  Eur J Case Rep Intern Med        ISSN: 2284-2594


  6 in total

1.  Reversible posterior leukoencephalopathy caused by azathioprine in systemic lupus erythematosus.

Authors:  Chingching Foocharoen; Somsak Tiamkao; Jiraporn Srinakarin; Nittaya Chamadol; Kittisak Sawanyawisuth
Journal:  J Med Assoc Thai       Date:  2006-07

Review 2.  Posterior reversible encephalopathy syndrome, part 1: fundamental imaging and clinical features.

Authors:  W S Bartynski
Journal:  AJNR Am J Neuroradiol       Date:  2008-03-20       Impact factor: 3.825

3.  Posterior reversible encephalopathy syndrome: a truly treatable neurologic illness.

Authors:  Esther V Hobson; Ian Craven; S Catrin Blank
Journal:  Perit Dial Int       Date:  2012 Nov-Dec       Impact factor: 1.756

Review 4.  [Posterior reversible encephalopathy syndrome].

Authors:  M Fischer; E Schmutzhard
Journal:  Med Klin Intensivmed Notfmed       Date:  2016-06-06       Impact factor: 0.840

5.  Refractory intracranial hypertension in posterior reversible encephalopathy syndrome.

Authors:  Alberto Facchini; Sandra Magnoni; Vittorio Civelli; Fabio Triulzi; Mario Nosotti; Nino Stocchetti
Journal:  Neurocrit Care       Date:  2013-12       Impact factor: 3.210

6.  Clinical spectrum of reversible posterior leukoencephalopathy syndrome.

Authors:  Vivien H Lee; Eelco F M Wijdicks; Edward M Manno; Alejandro A Rabinstein
Journal:  Arch Neurol       Date:  2008-02
  6 in total
  2 in total

1.  A Young Patient with Microscopic Polyangiitis Requiring Hemodialysis with Complications of Repeated Episodes of Posterior Reversible Encephalopathy Syndrome Probably Due to Different Etiologies.

Authors:  Shinichiro Asakawa; Shigeyuki Arai; Mika Kawagoe; Chiaki Ohata; Wataru Ono; Hiroshi Murata; Yoshifuru Tamura; Shunya Uchida; Shigeru Shibata; Yoshihide Fujigaki
Journal:  Intern Med       Date:  2021-10-12       Impact factor: 1.282

2.  A novel heterozygous mutation in the HMBS gene in a patient with acute intermittent porphyria and posterior reversible encephalopathy syndrome.

Authors:  Yang Yang; Xiyun Chen; Huijuan Wu; Hua Peng; Wenjing Sun; Bin He; Zhengang Yuan
Journal:  Mol Med Rep       Date:  2020-05-04       Impact factor: 2.952

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.